Search research articles
Contact Us
Filters
Showing results (1-10 of 229) with videos related to
Page
of 23
Sort By:
The European Respiratory Journal
|
May 20, 2022
Liver cancer in severe alpha-1 antitrypsin deficiency: who is at risk?
Malin Fromme, Pavel Strnad
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
July 23, 2020
Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency
Karim Hamesch, Pavel Strnad
International Journal of Molecular Sciences
|
March 25, 2022
Pathophysiology of Chronic Liver Disease Development
Malin Fromme, Pavel Strnad
Alimentary Pharmacology & Therapeutics
|
June 8, 2026
Editorial: Silent but Detectable-High Throughput Proteomics to Identify Clinically Significant Liver Disease. Authors' Reply
Katharina Remih, Pavel Strnad
Alimentary Pharmacology & Therapeutics
|
February 28, 2025
Editorial: Beyond Clinical Trials-Real-World Data Suggest Usefulness of GLP-1 RAs in MASLD Treatment
Lena Susanna Candels, Pavel Strnad
Respiratory Medicine
|
May 19, 2021
SARS-CoV-2 infection in alpha1-antitrypsin deficiency
Carolin V Schneider, Pavel Strnad
Expert Opinion on Investigational Drugs
|
July 20, 2023
RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease
Pavel Strnad, Javier San Martin
Alimentary Pharmacology & Therapeutics
|
February 10, 2021
Editorial: towards an understanding of increased mortality in coeliac disease-authors' reply
Carolin V Schneider, Pavel Strnad
Gastroenterology
|
March 26, 2009
Transglutaminase cross-links Sp1-mediated transcription to ethanol-induced liver injury
Pavel Strnad, M Bishr Omary
Current Opinion in Gastroenterology
|
May 5, 2023
Cleaning up alpha-1 antitrypsin deficiency related liver disease
Laura Rademacher, Malin Fromme, Pavel Strnad
Page
of 23
Search research articles
Search
Showing results (1-10 of 229) with videos related to
Sort By:
Page
of 23
The European Respiratory Journal
|
May 20, 2022
Liver cancer in severe alpha-1 antitrypsin deficiency: who is at risk?
Malin Fromme, Pavel Strnad
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)
|
July 23, 2020
Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency
Karim Hamesch, Pavel Strnad
International Journal of Molecular Sciences
|
March 25, 2022
Pathophysiology of Chronic Liver Disease Development
Malin Fromme, Pavel Strnad
Alimentary Pharmacology & Therapeutics
|
June 8, 2026
Editorial: Silent but Detectable-High Throughput Proteomics to Identify Clinically Significant Liver Disease. Authors' Reply
Katharina Remih, Pavel Strnad
Alimentary Pharmacology & Therapeutics
|
February 28, 2025
Editorial: Beyond Clinical Trials-Real-World Data Suggest Usefulness of GLP-1 RAs in MASLD Treatment
Lena Susanna Candels, Pavel Strnad
Respiratory Medicine
|
May 19, 2021
SARS-CoV-2 infection in alpha1-antitrypsin deficiency
Carolin V Schneider, Pavel Strnad
Expert Opinion on Investigational Drugs
|
July 20, 2023
RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease
Pavel Strnad, Javier San Martin
Alimentary Pharmacology & Therapeutics
|
February 10, 2021
Editorial: towards an understanding of increased mortality in coeliac disease-authors' reply
Carolin V Schneider, Pavel Strnad
Gastroenterology
|
March 26, 2009
Transglutaminase cross-links Sp1-mediated transcription to ethanol-induced liver injury
Pavel Strnad, M Bishr Omary
Current Opinion in Gastroenterology
|
May 5, 2023
Cleaning up alpha-1 antitrypsin deficiency related liver disease
Laura Rademacher, Malin Fromme, Pavel Strnad
Page
of 23